𝗦𝗰𝗮𝗹𝗶𝗻𝗴 𝗘𝗮𝗿𝗹𝘆 𝗗𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 𝗼𝗳 𝗗𝗶𝗮𝗯𝗲𝘁𝗶𝗰 𝗥𝗲𝘁𝗶𝗻𝗼𝗽𝗮𝘁𝗵𝘆 𝘄𝗶𝘁𝗵 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗔𝗻𝗻𝗼𝘁𝗮𝘁𝗶𝗼𝗻

Diabetic Retinopathy (DR) can cause irreversible vision loss, but early detection can make a significant difference. High-quality medical image annotation helps AI systems identify subtle retinal abnormalities more consistently.

𝗠𝗮𝗿𝗧𝗲𝗰𝗸 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 supports AI-driven ophthalmology initiatives with:

✅ Retinal lesion annotation – Microaneurysms, hemorrhages, exudates, and neovascularization
✅ Fundus & OCT annotation – Precise labeling of relevant anatomical structures and abnormalities
✅ Classification & segmentation – Supporting DR screening, grading, and progression analysis
✅ Expert medical review – Clinically informed annotation and multi-level quality checks
✅ Scalable workflows – Supporting projects from small research studies to high-volume clinical AI initiatives

𝗧𝘂𝗿𝗻𝗶𝗻𝗴 𝗥𝗲𝘁𝗶𝗻𝗮𝗹 𝗜𝗺𝗮𝗴𝗶𝗻𝗴 𝗶𝗻𝘁𝗼 𝗔𝗰𝘁𝗶𝗼𝗻𝗮𝗯𝗹𝗲 𝗔𝗜 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀

With specialized medical annotation and labeling services, MarTeck Solutions helps healthcare organizations, researchers, and AI teams build reliable foundations for next-generation diabetic retinopathy screening and clinical decision support.

Building an ophthalmology AI project? Let’s connect with MarTeck Solutions and discuss your annotation requirements.